Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Operations and Comprehensive Loss

v3.23.1
Consolidated Statements of Operations and Comprehensive Loss - USD ($)
shares in Thousands, $ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Income Statement [Abstract]    
Revenue $ 12,912 $ 11,246
Cost of revenue 6,698 4,497
Gross profit 6,214 6,749
Operating expenses:    
Sales and marketing 7,157 7,305
Research and development 3,626 2,549
General and administrative 10,987 10,723
Total operating expenses 21,770 20,577
Loss from operations (15,556) (13,828)
Other (expense) income, net:    
Interest expense (156) (113)
Gain on revaluation of warrant liabilities 1,317 3,962
Gain on forgiveness of note payable 0 1,099
Unrealized loss on foreign exchange (655) (867)
Other expense, net (30) (17)
Total other income, net 476 4,064
Net loss (15,080) (9,764)
Foreign currency translation adjustments 580 830
Comprehensive loss $ (14,500) $ (8,934)
Basic net loss per share applicable to common shareholders (in dollars per share) $ (1.16) $ (0.80)
Diluted net loss per share applicable to common shareholders (in dollars per share) $ (1.16) $ (0.88)
Weighted-average number of shares outstanding, basic (in shares) 12,962 12,193
Weighted average number of shares outstanding, diluted (in shares) 12,962 12,269